The brain is the most complex organ in the body, and it is currently not financially or logistically feasible to non-invasively remotely monitor the brain. Thereby making ambulatory longitudinal studies extremely difficult. Existing non-invasive EEG devices attach to the skull exterior via wet electrodes, are unable to obtain deep brain signals. Currently the only way to obtain a deep brain signal is by embedding electrodes into the brain through highly invasive brain surgery.

Aware is the first non-invasive medical device to obtain a deep brain signal allowing for remote monitoring of the brain along with a myriad of other biometrics. Built into a custom earphone and integrated into a machine learning platform, Aware can obtain accurate and repeatable brain monitoring EEG signals via the ear canal. Aware's learning algorithms enable customization for specific medical domains which can be tied to a specific treatment.

Sam Kellett, Jr. is the Founder and CEO of Aware. Sam led the development of the world's first custom biometric hearable that remotely monitors the brain. Sam also led the development of the custom biometric hearable enabling technology, the Otoscan and eFit 3D ear scanners. The Otoscan and eFit 3D ear scanners are now the industry standard in the hearing aid and custom in-ear monitor industries.

Before Aware Sam was a successful entrepreneur with years of experience in the hardware and software technology sectors. Sam was founder and CEO of a technology company that he sold to Reed Elsevier. Sam is also an advisory board member at the College of Computing at the Georgia Institute of Technology and was also appointed by the Governor of Georgia to the Jekyll Island Port Authority Board and Public Schools Retirement Pension Board. Sam holds an undergraduate degree from North Carolina State University and holds an MBA from the University of Georgia.

Aware is the world's leading custom biometric hearable platform that remotely monitors the brain for seizure detection and neurodegenerative disorders. Built into a custom earphone and integrated into a machine learning platform, Aware can non-invasively obtain accurate and repeatable brain monitoring EEG signals and a myriad of other biometrics for specific medical domains. Aware is currently providing custom biometric hearables to pharmaceutical companies for their patient trials for new drug development. Aware sells custom biometric hearables to pharmaceutical companies and leading research hospitals, and licenses the entire platform or subsets to large companies. Aware is headquartered in Atlanta, GA with customers and partners from around the world.